The Pune-based Serum Institute of India (SII) on Tuesday announced a further collaboration with the Global Alliance for Vaccines and Immunizations (GAVI) and the Bill & Melinda Gates Foundation to accelerate the manufacture and delivery of an additional 100 million doses of COVID-19 vaccines for India and low- and middle-income countries (LMICs).
This expansion brings the total number of vaccine doses to be covered by the partnership between the SII, GAVI, and the Gates Foundation to an aggregate of up to 200 million doses, following the initial agreement for up to 100 million doses announced in August this year.
The Gates Foundation, via its strategic investment fund, will provide at-risk funding of a further $150 million to GAVI, bringing the total funding provided through this collaboration to $300 million, the SII said in a statement. This funding will be used to support SII to…
